2016 – INBT Undergraduate symposium
Frontiers of Medicine – Biological and Engineering Research Driving the State of Health
The second INBT undergraduate organized research symposium will take place on Thursday, November 10th, 2016.
- 12:00 pm: Check in
- 12:45 pm: Keynote Speaker
- 1:00 pm: Student Talks
- 2:00 pm: 1st Poster Session
- 3:15 pm: 2nd Poster Session
- 4:30 pm: Awards
Please note: You must be able to be present for your assigned round of poster presentation. Please state when you are available in the application below.
Prizes will be awarded!
Free poster printing!
Applications close October 14th at 12 pm EST
2016 – Precision Medicine
Johns Hopkins Institute for NanoBioTechnology celebrated its tenth anniversary at their annual symposium with the theme of Precision Medicine. According to the National Institutes of Health: Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. While some advances in precision medicine have been made, the practice is not currently in use for most diseases. That’s why on January 20, 2015, President Obama announced the Precision Medicine Initiative® (PMI) in his State of the Union address. Through advances in research, technology and policies that empower patients, the PMI will enable a new era of medicine in which researchers, providers and patients work together to develop individualized care.
2015 – Neuro X
2014 – Stem Cell Science and Engineering: State of the Art
Faculty experts gathered Friday, May 2, at the Owens Auditorium at the Johns Hopkins School of Medicine to discuss the clinical, the engineering and the commercial aspects of stem cells. Speakers included Linzhao Cheng, PhD, Oncology/Stem Cell program, JHMI; Linda M. S. Resar, MD, Oncology/ICE JHMI; Hai-Quan Mao, PhD, Materials Science and Engineering, JHU; Warren Grayson, PhD, Biomedical Engineering, JHU; Mark Powers, PhD, R&D Thermo Fisher Scientific; and Gou-li Ming, PhD, Neurology/ICE JHMI.
2013 – Translating the Promise of Nanoscience from Laboratory to Development
Held at Shriver Auditorium Friday, May 17 on the Homewood campus. Speakers included industry and faculty experts who are succuessfully translating their science and engineering innovations into technologies that can help people and solve problems in healthcare and medicine. An afternoon poster session featured the nano-bio related research from laboratories across the University system, including work from the Johns Hopkins School of Medicine, School of Public Health, Krieger School of Arts and Sciences, Whiting School of Engineering and the Applied Physics Laboratory.
2012 – Cancer: The Big Picture
Exploring the diagnosis and treatment of cancer from a variety of novel approaches using epidemiology, physical sciences, genetics, and cell biology. The sixth annual symposium of Johns Hopkins Institute for NanoBioTechnology (INBT) was held on May 4, 2012 at the university’s Medical Campus.
2011 – Nanotechnology for Cancer Medicine
Nanotechnology for Cancer Medicine formed the focus of the fifth annual symposium of Johns Hopkins Institute for NanoBioTechnology (INBT). The event was held on May 12-13, 2011 at the university’s Homewood campus.
2010 – Environmental and Health Impacts of Engineered Nanomaterials
Johns Hopkins Institute for NanoBioTechnology 4th Annual Symposium was held on Thursday, April 29th, 2010 at the Johns Hopkins Bloomberg School of Public Health.
2009 – Nanoscience for Neuroscience and Neurosurgery
Nanoscience for Neuroscience and Neurosurgery, INBT’s 3rd annual symposium was held Monday, May 18, 2009 in Mountcastle Auditorium of the PreClinical Teaching Building. A poster session was held in Turner Concourse on the Johns Hopkins medical campus. Speakers from the Johns Hopkins School of Medicine included Ted Dawson, Abramson Professor of Neurodegenerative Diseases; John W. Griffin, Johns Hopkins University Distinguished Service Professor of Neurology, Neuroscience and Pathology and director of the Brain Science Institute; Michael T. McMahon, assistant professor of Radiology, MR Division; Alessandro Olivi, professor of Neurosurgery and Oncology and chair of Neurosurgery at Johns Hopkins Bayview Medical Center; and Jeffrey Rothstein, professor of Neurology and director of the Robert Packard Center for ALS Research.
2008 – Nanotechnology for Cancer
All facets of research relating to the emerging discipline of nanobiotechnology were explored at the second annual Johns Hopkins NanoBio Symposium, May 1 -2, 2008. “Nanotechnology for Cancer“ was the focus of Thursday’s workshop, co-hosted by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This workshop featured short presentations and engaging discussions with several Johns Hopkins faculty experts working in areas relating to nanobiotechnology. Invited speakers included Donald E. Ingber, M.D., Ph.D., professor or vascular biology from the Harvard Medical School; Andrew D. Maynard, Ph.D., chief science advisor for the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars; Paras N. Prasad, Ph.D., director of the Institute for Lasers, Photonics, and Biophotonics at the University at Buffalo; Jeffery A. Schloss, Ph.D., from the National Human Genome Research Institute; and Jennifer L. West, Ph.D., professor of bioengineering at Rice University.
The first annual symposium for nanobiotechnology at Johns Hopkins Universtity was held on Friday, April 27, 2007 on the Homewood campus. Speakers included Michael P.Sheetz, Prof., Biological Sciences, Columbia University; David J. Mooney, Prof., Bioengineering, Harvard University; Günter Oberdörster, Prof., Environmental Medicine, University of Rochester; Dennis Discher, Prof., Chemical and Biomolecular Engineering, University of Pennsylvania; Gang Bao, Prof, Biomedical Engineering, Georgia Institute of Technology; Wendy Sanhai, Senior Scientific Advisor, FDA; Greg Downing, Director, Office of Technology and Industrial Relationships, NCI; and Piotr Grodzinski, Director, Nanotechnology Alliance for Cancer, NCI.